Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ascorbic acid + paracetamol + pheniramine + phenylephrine
- Development stage
- Unknown
- Lead developer
- Astrapharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Astracytron Extra is an over-the-counter (OTC) fixed-dose combination medication developed and manufactured by Astrapharm for the symptomatic relief of acute respiratory viral infections (ARVI) and influenza. It contains four active ingredients: paracetamol (an analgesic and antipyretic), phenylephrine hydrochloride (a decongestant), pheniramine maleate (an antihistamine), and ascorbic acid (vitamin C). Together, these components work synergistically to reduce fever, alleviate headaches and muscle aches, relieve nasal congestion, and support the immune system during viral infections. The drug is formulated as a powder for oral solution in sachets.
- Brand names
- AstracytronAstracytron ExtraAstracytron ForteNeoCitran GrippeTherafluTheraflu Cold and FluTheraflu ExtraTheraflu ExtraGRIP
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)ADRA1A (α1A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on ascorbic acid + paracetamol + pheniramine + phenylephrine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ascorbic acid + paracetamol + pheniramine + phenylephrine.